Global Monkeypox Virus Vaccine Market Growth 2026-2032

September 2026 | 78 pages | ID: G278473FDC6BEN
LP Information

Abstracts

The global Monkeypox Virus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Monkeypox Virus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Monkeypox Virus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Monkeypox Virus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Monkeypox Virus Vaccine players cover Bavarian Nordic, Sanofi Pasteur Biologics, KM Biologics, Yatai Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Monkeypox Virus Vaccine Industry Forecast” looks at past sales and reviews total world Monkeypox Virus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Monkeypox Virus Vaccine sales for 2026 through 2032. With Monkeypox Virus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Virus Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Monkeypox Virus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Virus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monkeypox Virus Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Virus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Virus Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Virus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• MVA-BN
• LC16
• OrthopoxVac

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bavarian Nordic
• Sanofi Pasteur Biologics
• KM Biologics
• Yatai Group

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Monkeypox Virus Vaccine market?
• What factors are driving Monkeypox Virus Vaccine market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Monkeypox Virus Vaccine market opportunities vary by end market size?
• How does Monkeypox Virus Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Monkeypox Virus Vaccine Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Monkeypox Virus Vaccine by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Monkeypox Virus Vaccine by Country/Region, 2021, 2025 & 2032
  2.2 Monkeypox Virus Vaccine Segment by Type
  2.2.1 MVA-BN
  2.2.2 LC16
  2.2.3 OrthopoxVac
  2.2.4 Monkeypox Virus Vaccine Sales by Type
  2.2.4.1 Global Monkeypox Virus Vaccine Sales Market Share by Type (2021-2026)
  2.2.4.2 Global Monkeypox Virus Vaccine Revenue and Market Share by Type (2021-2026)
  2.2.4.3 Global Monkeypox Virus Vaccine Sale Price by Type (2021-2026)
  2.3 Monkeypox Virus Vaccine Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Monkeypox Virus Vaccine Sales by Application
  2.3.4.1 Global Monkeypox Virus Vaccine Sale Market Share by Application (2021-2026)
  2.3.4.2 Global Monkeypox Virus Vaccine Revenue and Market Share by Application (2021-2026)
  2.3.4.3 Global Monkeypox Virus Vaccine Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Monkeypox Virus Vaccine Breakdown Data by Company
  3.1.1 Global Monkeypox Virus Vaccine Annual Sales by Company (2021-2026)
  3.1.2 Global Monkeypox Virus Vaccine Sales Market Share by Company (2021-2026)
  3.2 Global Monkeypox Virus Vaccine Annual Revenue by Company (2021-2026)
  3.2.1 Global Monkeypox Virus Vaccine Revenue by Company (2021-2026)
  3.2.2 Global Monkeypox Virus Vaccine Revenue Market Share by Company (2021-2026)
  3.3 Global Monkeypox Virus Vaccine Sale Price by Company
  3.4 Key Manufacturers Monkeypox Virus Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Monkeypox Virus Vaccine Product Location Distribution
  3.4.2 Players Monkeypox Virus Vaccine Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MONKEYPOX VIRUS VACCINE BY GEOGRAPHIC REGION

  4.1 World Historic Monkeypox Virus Vaccine Market Size by Geographic Region (2021-2026)
  4.1.1 Global Monkeypox Virus Vaccine Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Monkeypox Virus Vaccine Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Monkeypox Virus Vaccine Market Size by Country/Region (2021-2026)
  4.2.1 Global Monkeypox Virus Vaccine Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Monkeypox Virus Vaccine Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Monkeypox Virus Vaccine Sales Growth
  4.4 APAC Monkeypox Virus Vaccine Sales Growth
  4.5 Europe Monkeypox Virus Vaccine Sales Growth
  4.6 Middle East & Africa Monkeypox Virus Vaccine Sales Growth

5 AMERICAS

  5.1 Americas Monkeypox Virus Vaccine Sales by Country
  5.1.1 Americas Monkeypox Virus Vaccine Sales by Country (2021-2026)
  5.1.2 Americas Monkeypox Virus Vaccine Revenue by Country (2021-2026)
  5.2 Americas Monkeypox Virus Vaccine Sales by Type (2021-2026)
  5.3 Americas Monkeypox Virus Vaccine Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Monkeypox Virus Vaccine Sales by Region
  6.1.1 APAC Monkeypox Virus Vaccine Sales by Region (2021-2026)
  6.1.2 APAC Monkeypox Virus Vaccine Revenue by Region (2021-2026)
  6.2 APAC Monkeypox Virus Vaccine Sales by Type (2021-2026)
  6.3 APAC Monkeypox Virus Vaccine Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Monkeypox Virus Vaccine by Country
  7.1.1 Europe Monkeypox Virus Vaccine Sales by Country (2021-2026)
  7.1.2 Europe Monkeypox Virus Vaccine Revenue by Country (2021-2026)
  7.2 Europe Monkeypox Virus Vaccine Sales by Type (2021-2026)
  7.3 Europe Monkeypox Virus Vaccine Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Monkeypox Virus Vaccine by Country
  8.1.1 Middle East & Africa Monkeypox Virus Vaccine Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Monkeypox Virus Vaccine Revenue by Country (2021-2026)
  8.2 Middle East & Africa Monkeypox Virus Vaccine Sales by Type (2021-2026)
  8.3 Middle East & Africa Monkeypox Virus Vaccine Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Monkeypox Virus Vaccine
  10.3 Manufacturing Process Analysis of Monkeypox Virus Vaccine
  10.4 Industry Chain Structure of Monkeypox Virus Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Monkeypox Virus Vaccine Distributors
  11.3 Monkeypox Virus Vaccine Customer

12 WORLD FORECAST REVIEW FOR MONKEYPOX VIRUS VACCINE BY GEOGRAPHIC REGION

  12.1 Global Monkeypox Virus Vaccine Market Size Forecast by Region
  12.1.1 Global Monkeypox Virus Vaccine Forecast by Region (2027-2032)
  12.1.2 Global Monkeypox Virus Vaccine Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Monkeypox Virus Vaccine Forecast by Type (2027-2032)
  12.7 Global Monkeypox Virus Vaccine Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Bavarian Nordic
  13.1.1 Bavarian Nordic Company Information
  13.1.2 Bavarian Nordic Monkeypox Virus Vaccine Product Portfolios and Specifications
  13.1.3 Bavarian Nordic Monkeypox Virus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Bavarian Nordic Main Business Overview
  13.1.5 Bavarian Nordic Latest Developments
  13.2 Sanofi Pasteur Biologics
  13.2.1 Sanofi Pasteur Biologics Company Information
  13.2.2 Sanofi Pasteur Biologics Monkeypox Virus Vaccine Product Portfolios and Specifications
  13.2.3 Sanofi Pasteur Biologics Monkeypox Virus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Sanofi Pasteur Biologics Main Business Overview
  13.2.5 Sanofi Pasteur Biologics Latest Developments
  13.3 KM Biologics
  13.3.1 KM Biologics Company Information
  13.3.2 KM Biologics Monkeypox Virus Vaccine Product Portfolios and Specifications
  13.3.3 KM Biologics Monkeypox Virus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 KM Biologics Main Business Overview
  13.3.5 KM Biologics Latest Developments
  13.4 Yatai Group
  13.4.1 Yatai Group Company Information
  13.4.2 Yatai Group Monkeypox Virus Vaccine Product Portfolios and Specifications
  13.4.3 Yatai Group Monkeypox Virus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Yatai Group Main Business Overview
  13.4.5 Yatai Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Monkeypox Virus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Monkeypox Virus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of MVA-BN
Table 4. Major Players of LC16
Table 5. Major Players of OrthopoxVac
Table 6. Global Monkeypox Virus Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Monkeypox Virus Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Monkeypox Virus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Monkeypox Virus Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Monkeypox Virus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Monkeypox Virus Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Monkeypox Virus Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Monkeypox Virus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Monkeypox Virus Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Monkeypox Virus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Monkeypox Virus Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Monkeypox Virus Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Monkeypox Virus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Monkeypox Virus Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Monkeypox Virus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Monkeypox Virus Vaccine Producing Area Distribution and Sales Area
Table 22. Players Monkeypox Virus Vaccine Products Offered
Table 23. Monkeypox Virus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Monkeypox Virus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Monkeypox Virus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Monkeypox Virus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Monkeypox Virus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Monkeypox Virus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Monkeypox Virus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Monkeypox Virus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Monkeypox Virus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Monkeypox Virus Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Monkeypox Virus Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Monkeypox Virus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Monkeypox Virus Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Monkeypox Virus Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Monkeypox Virus Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Monkeypox Virus Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Monkeypox Virus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Monkeypox Virus Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Monkeypox Virus Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Monkeypox Virus Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Monkeypox Virus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Monkeypox Virus Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Monkeypox Virus Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Monkeypox Virus Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Monkeypox Virus Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Monkeypox Virus Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Monkeypox Virus Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Monkeypox Virus Vaccine
Table 53. Key Market Challenges & Risks of Monkeypox Virus Vaccine
Table 54. Key Industry Trends of Monkeypox Virus Vaccine
Table 55. Monkeypox Virus Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Monkeypox Virus Vaccine Distributors List
Table 58. Monkeypox Virus Vaccine Customer List
Table 59. Global Monkeypox Virus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Monkeypox Virus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Monkeypox Virus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Monkeypox Virus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Monkeypox Virus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Monkeypox Virus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Monkeypox Virus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Monkeypox Virus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Monkeypox Virus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Monkeypox Virus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Monkeypox Virus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Monkeypox Virus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Monkeypox Virus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Monkeypox Virus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Bavarian Nordic Basic Information, Monkeypox Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Bavarian Nordic Monkeypox Virus Vaccine Product Portfolios and Specifications
Table 75. Bavarian Nordic Monkeypox Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Bavarian Nordic Main Business
Table 77. Bavarian Nordic Latest Developments
Table 78. Sanofi Pasteur Biologics Basic Information, Monkeypox Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Biologics Monkeypox Virus Vaccine Product Portfolios and Specifications
Table 80. Sanofi Pasteur Biologics Monkeypox Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Pasteur Biologics Main Business
Table 82. Sanofi Pasteur Biologics Latest Developments
Table 83. KM Biologics Basic Information, Monkeypox Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. KM Biologics Monkeypox Virus Vaccine Product Portfolios and Specifications
Table 85. KM Biologics Monkeypox Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. KM Biologics Main Business
Table 87. KM Biologics Latest Developments
Table 88. Yatai Group Basic Information, Monkeypox Virus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Yatai Group Monkeypox Virus Vaccine Product Portfolios and Specifications
Table 90. Yatai Group Monkeypox Virus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Yatai Group Main Business
Table 92. Yatai Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Monkeypox Virus Vaccine
Figure 2. Monkeypox Virus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monkeypox Virus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Monkeypox Virus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Monkeypox Virus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Monkeypox Virus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Monkeypox Virus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of MVA-BN
Figure 12. Product Picture of LC16
Figure 13. Product Picture of OrthopoxVac
Figure 14. Global Monkeypox Virus Vaccine Sales Market Share by Type in 2026
Figure 15. Global Monkeypox Virus Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Monkeypox Virus Vaccine Consumed in Hospital
Figure 17. Global Monkeypox Virus Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 18. Monkeypox Virus Vaccine Consumed in Clinic
Figure 19. Global Monkeypox Virus Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 20. Monkeypox Virus Vaccine Consumed in Others
Figure 21. Global Monkeypox Virus Vaccine Market: Others (2021-2026) & (K Units)
Figure 22. Global Monkeypox Virus Vaccine Sale Market Share by Application (2025)
Figure 23. Global Monkeypox Virus Vaccine Revenue Market Share by Application in 2026
Figure 24. Monkeypox Virus Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global Monkeypox Virus Vaccine Sales Market Share by Company in 2026
Figure 26. Monkeypox Virus Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Monkeypox Virus Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Monkeypox Virus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Monkeypox Virus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Monkeypox Virus Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas Monkeypox Virus Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Monkeypox Virus Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC Monkeypox Virus Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Monkeypox Virus Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe Monkeypox Virus Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Monkeypox Virus Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Monkeypox Virus Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Monkeypox Virus Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Monkeypox Virus Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Monkeypox Virus Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Monkeypox Virus Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Monkeypox Virus Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Monkeypox Virus Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Monkeypox Virus Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Monkeypox Virus Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Monkeypox Virus Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Monkeypox Virus Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Monkeypox Virus Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Monkeypox Virus Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Monkeypox Virus Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Monkeypox Virus Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Monkeypox Virus Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Monkeypox Virus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Monkeypox Virus Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Monkeypox Virus Vaccine
Figure 76. Industry Chain Structure of Monkeypox Virus Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Monkeypox Virus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Monkeypox Virus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Monkeypox Virus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Monkeypox Virus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Monkeypox Virus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Monkeypox Virus Vaccine Revenue Market Share Forecast by Application (2027-2032)